HEATHER SWANN: Open Payments
NPI 1407583776 · BOUNTIFUL, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,893 in 107 payments from 19 companies in 2025. Trend: 2023 $116 · 2024 $2,364 · 2025 $1,893
Food & beverage: $1,884Education: $9
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $380 |
| Janssen Biotech, Inc. | 22 | $312 |
| Madrigal Pharmaceuticals | 6 | $201 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $187 |
| Ardelyx, Inc. | 8 | $160 |
| GENZYME CORPORATION | 7 | $149 |
| Aimmune Therapeutics, Inc. | 5 | $109 |
| Celltrion USA Inc. | 3 | $81 |
| QOL Medical, LLC | 3 | $55 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, DUPIXENT, ENTYVIO, IBSRELA, SKYRIZI, VOWST.
Industry payments across UT — which companies pay providers there.
